(Q39743346)

English

Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects

scientific article

Statements

Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects (English)
1 reference
Laurene H Wang
1 reference
Richard W Peck
1 reference
Yin Yin
1 reference
Jane Allanson
1 reference
Rebecca Wiggs
1 reference
Mary Beth Wire
1 reference
1 April 2003
1 reference
47
1 reference
4
1 reference
1334-1342
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit